BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

B.Braun Medical Announces Settlement


12/8/2010 10:38:33 AM

BETHLEHEM, Pa., Dec. 7, 2010/PRNewswire/ --B. Braun Medical Inc. (B. Braun) has entered into a settlement agreement in the amount of $14.7 million with the Department of Justice to resolve a long-standing dispute relating to pricing information published by third parties for certain pharmaceutical products manufactured by B. Braun. The matter was part of an industry-wide investigation arising out of a qui tam action filed under seal in the Southern District of Florida in 1995 by Ven-a-Care of the Florida Keys against B. Braun's predecessor in interest, McGaw, Inc.

(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO )

The settlement resolves all disputes between B. Braun and the federal government, and after 15 years, B. Braun is happy to have this matter behind it. B. Braun denies all allegations of wrongdoing and has entered into the settlement agreement to avoid excessive ongoing legal costs. B. Braun complies with government laws and regulations and operates under a robust compliance program to ensure continual compliance. As such, B. Braun was not required to enter into a corporate integrity agreement as part of the settlement.

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, email us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.

SOURCE B. Braun Medical Inc.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->